ELLA-CS

What ELLA-CS does

ELLA-CS, s.r.o. is a Czech medical device manufacturer specializing in stents for the digestive tract (gastroenterology) and respiratory tract (pneumology). Headquartered in Hradec Králové, Czech Republic, the company designs, manufactures, and distributes esophageal and airway stents to hospitals and healthcare institutions worldwide. Its commercial product portfolio centers on the BD STENT, a biodegradable esophageal stent described by the company as worldwide unique, the DANIS STENT for critical esophageal conditions, and the HV STENT Plus for digestive and respiratory obstructions. The company is also developing a Hybrid Stent combining biodegradable and metallic components, with a patent application filed. Underlying technology is rooted in materials science and mechanical stent design — notably proprietary biodegradable polymer stent architecture that eliminates the need for removal procedures — rather than software or AI.

The company's business model is B2B medical device manufacturing, executed via direct institutional sales to hospitals and healthcare providers globally. Revenue is generated through two streams: (1) hardware sales of its proprietary stent portfolio and (2) OEM and contract manufacturing services for third-party medical device partners. Go-to-market is enterprise field sales, supported by participation in international medical conferences and trade fairs (ESGE Days, MedtecLIVE, WHX) and professional website content directed at healthcare professionals. Pricing is not publicly disclosed and is handled through direct quotation and procurement processes typical of medical device institutional sales. The primary customer segment is acute care hospitals, university medical centers, and specialized healthcare facilities performing gastroenterology and pneumology procedures; a secondary patient-facing segment is targeted through patient education resources.

ELLA-CS operates as a privately held limited liability company (s.r.o.) with no disclosed parent company, no external investment or venture backing, and no subsidiaries. The firm has accumulated 30 years of manufacturing experience, holds multiple Czech and European quality and innovation awards (including Czech Innovation Award 2012, European Business Awards National Winner 2014/2018/2019, Safe Enterprise 2025, and Ambassador of Quality Czech Republic 2025), and is pursuing EU MDR 2017/745 quality management system certification. Its R&D, clinical trials, commercialization preparation, and export market expansion activities have received co-sponsorship from the European Union and Czech Republic, supporting a long-term, government-aligned innovation and internationalization strategy.

Name

ELLA-CS

Legal name

ELLA-CS, s.r.o.

Website

https://ellacs.eu

Company type

Private

Founded year

1995

Operating status

Operating

Headcount range

11–50 employees

Short description

ELLA-CS, s.r.o. is a Czech medical device manufacturer that designs and sells proprietary biodegradable and conventional esophageal and airway stents to hospitals and healthcare institutions worldwide, complemented by OEM and contract manufacturing services.

Ownership category

akta.pro rank

Product category

Medical Devices (Gastroenterology and Pneumology Stents)

NAICS

Surgical Appliance and Supplies Manufacturing (339113)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Coronary Stents & Drug-Eluting Technologies (HLAHAFAA)

akta.pro secondary industry

Peripheral Vascular Intervention (PAD Stents, Balloons, Atherectomy) (HLAHAFAE)

Keywords

• Medical stents
• Gastroenterology devices
• Biodegradable stents
• Esophageal stents
• Pneumology devices

Headquarters

HQ city

Hradec Kralove

HQ country

Czechia

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

1. Medical Device Sales: ELLA-CS generates revenue through the manufacture and sale of medical stents and related medical devices for gastroenterology and pneumology applications to healthcare institutions worldwide.
2. OEM and Contract Manufacturing: The company offers cooperation in projects through OEM (Original Equipment Manufacturing) and contract manufacturing services for medical devices.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

ELLA-CS manufactures and sells specialized medical stents for gastroenterology and pneumology applications. Its portfolio includes the BD STENT (a worldwide unique biodegradable esophageal stent that dissolves in the body), the DANIS STENT (a life-saving esophageal stent for critical conditions), and the HV STENT Plus (esophageal/airway stent). The company also offers OEM and contract manufacturing services for medical devices.

Product overview

ELLA-CS is a Czech medical device manufacturer specializing in gastroenterology and pneumology stents. The company offers a portfolio of esophageal and airway stents, including the BD STENT (biodegradable esophageal stent), DANIS STENT (life-saving esophageal stent), and HV STENT Plus. The company also develops a Hybrid Stent combining biodegradable and metallic technologies. ELLA-CS supplies its unique stents worldwide, with products designed for the digestive tract and airway applications. The company operates in gastroenterology and pneumology categories.

Differentiator

Problem solved

Functional benefit

Brands

• BD STENT: Worldwide unique biodegradable esophageal stent
• DANIS STENT
• HV Stent Plus

Products and services

• BD STENT A worldwide unique biodegradable esophageal stent designed for treatment of esophageal strictures and obstructions; dissolves in the body over time, eliminating the need for removal procedures. Targeted at gastroenterology specialists and hospitals.
• DANIS STENT A life-saving esophageal stent designed for urgent and critical esophageal conditions, providing structural support and palliation for patients with esophageal obstructions. Used by hospitals and gastroenterology specialists.
• HV STENT Plus An esophageal/airway stent designed to restore hope for patients with limitations due to digestive or respiratory tract obstructions, helping patients return to normal life. Targeted at hospitals and specialists treating airway and digestive tract obstructions.
• OEM and Contract Manufacturing Services Cooperation in projects in the form of OEM (Original Equipment Manufacturing) and contract manufacturing for medical devices. Targeted at medical device companies seeking manufacturing partners.

Quantifiable outcome

• 303 days hospitalization reduced to discharge after biodegradable stent implantation

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• European Union and Czech RepubliccoreOthers · 1 January 2020EU and Czech Republic co-sponsorship of multiple research and development projects including biodegradable stent development, commercialization preparation, clinical trials, and quality management system certification (MDR compliance). Multiple projects supported including marketing initiatives, 3D animation development, and export market expansion.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Taewoong Medical: Taewoong Medical is a Korea-based specialist in GI and airway stents (Niti-S, etc.) and is the most direct global competitor to ELLA-CS in the esophageal and biliary stent space, with comparable indications and physician customers.
• Merit Medical Systems: Merit Medical manufactures non-vascular stent systems (including esophageal and airway platforms) and competes head-to-head with ELLA-CS in gastroenterology and pneumology stents sold to hospitals worldwide.
• Cook Medical: Cook Medical is a leading direct competitor in GI and airway stents, offering a broad portfolio of esophageal, biliary, and bronchial stents — overlapping directly with ELLA-CS's core product categories of gastroenterology and pneumology stent systems.
• Leufen Medical: Leufen Medical is a European specialist in airway and esophageal stents with comparable positioning to ELLA-CS, serving pulmonologists and gastroenterologists with overlapping indications.
• Hood Laboratories: Hood Laboratories produces silicone airway stents and related products for pneumology, overlapping with ELLA-CS's airway stent offerings and competing for the same ENT and pulmonology customers.

Broad incumbents

• Medtronic: Medtronic is a broad incumbent in medical devices and competes with ELLA-CS in airway and esophageal stent categories (e.g., EndoFLX heritage airway products, Wallstent legacy esophageal portfolio), representing a much larger competitor with deep sales infrastructure.
• Olympus Corporation: Olympus is a leading player in GI endoscopy and supplies complementary devices including esophageal stents through partnered portfolios, competing with ELLA-CS in the same gastroenterology procedure workflows and hospital channels.
• Boston Scientific: Boston Scientific is a global broad incumbent in endoscopy and interventional medicine, with a large GI stent franchise (WallFlex, Ultraflex) directly competing with ELLA-CS in esophageal stenting, while also serving as a benchmark on commercialization scale and regulatory footprint.

Emerging players

• M.I. Tech: M.I. Tech (Korea) is an emerging player in GI and airway stents (Hanarostent family), competing with ELLA-CS in similar endoscopic indications across European and Asian export markets.
• Micro-Tech (Nanjing): Micro-Tech is a Chinese manufacturer of GI endoscopic accessories including stents, providing a low-cost emerging alternative to ELLA-CS in international tenders and emerging markets.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/ellacs.cz
• LinkedInlinkedin.com/company/ella-cs

Compliance18 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ELLA-CS